REGN
Regeneron Pharmaceuticals Inc
Price:  
1,039.11 
USD
Volume:  
379,246.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron EV/EBITDA

-45.5%
Upside

As of 2024-06-19, the EV/EBITDA ratio of Regeneron Pharmaceuticals Inc (REGN) is 26.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Regeneron's latest enterprise value is 114,600.83 mil USD. Regeneron's TTM EBITDA according to its financial statements is 4,392.90 mil USD. Dividing these 2 quantities gives us the above Regeneron EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.7x - 14.3x 12.5x
Forward P/E multiples 10.4x - 17.5x 14.0x
Fair Price 425.65 - 797.60 566.51
Upside -59.0% - -23.2% -45.5%
1,039.11 USD
Stock Price
566.51 USD
Fair Price

Regeneron EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-18 26.09
2024-06-17 26.24
2024-06-14 26.02
2024-06-13 25.77
2024-06-12 25.80
2024-06-11 25.37
2024-06-10 25.15
2024-06-07 25.18
2024-06-06 25.13
2024-06-05 25.25
2024-06-04 24.94
2024-06-03 24.84
2024-05-31 24.61
2024-05-30 24.35
2024-05-29 24.27
2024-05-28 24.43
2024-05-24 24.73
2024-05-23 24.62
2024-05-22 24.70
2024-05-21 24.95
2024-05-20 24.79
2024-05-17 24.66
2024-05-16 24.30
2024-05-15 24.56
2024-05-14 24.72
2024-05-13 24.53
2024-05-10 24.45
2024-05-09 24.30
2024-05-08 24.00
2024-05-07 24.35
2024-05-06 24.07
2024-05-03 24.03
2024-05-02 23.54
2024-05-01 22.69
2024-04-30 22.36
2024-04-29 22.41
2024-04-26 22.18
2024-04-25 22.36
2024-04-24 22.76
2024-04-23 22.78
2024-04-22 22.60
2024-04-19 22.52
2024-04-18 22.45
2024-04-17 22.63
2024-04-16 22.45
2024-04-15 22.56
2024-04-12 22.72
2024-04-11 23.11
2024-04-10 23.51
2024-04-09 23.70